Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07685405

Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas

The study involves blood samples from patients with Ewing's sarcoma to identify circulating biomarkers as a tool for the preclinical validation of innovative therapeutic approaches

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sarcoma, Ewing Neoplasms Neoplasms by Histologic Type Neoplasms, Bone Tissue Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Osteosarcoma Sarcoma

Sex eligibility

All sexes

Study type

Observational

Primary location

Istituto ortopedico Rizzoli Laboratorio di Ricerc Oncologica e Genomica funzioanle

Bologna, BO, 40136, Italy

Location status: Recruiting

Location contact

Katia Scotlandi, MSc

CONTACT

[email protected]

390516366760

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for cancer patients

  • Male and female patients of any age diagnosed with Ewing sarcoma.
  • Signed, study-specific informed consent form for the BIOVES study (cancer patients)

Inclusion criteria

for non-cancer patients

  • Male and female patients of legal age without a cancer diagnosis.
  • Signed, study-specific informed consent form for the BIOVES study (non-cancer patients)

Exclusion criteria

Patients who do not meet all inclusion criteria

-

Treatment and study plan

one blood sample

Other

non onco

3 blood samples

Other

onco

Primary outcomes

  1. characterisation of circulating biomarkers

    Time frame: at baseline (time 0); before surgery; after 6 months from surgery

    search for circulating biomarkers from blood samples taken at three different time points

Study contacts

Contact information is provided by the study sponsor or research team.

Katia Scotlandi, MSc

CONTACT

[email protected]

39 051 6366760

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Official study title

Feasibility Study for the Identification of Circulating Biomarkers Associated With Extracellular Vesicles in Sarcomas

Acronym: BIOVES

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jul 6, 2026
Registry last updated
Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.